Nucleoside phosphoramidates
US8618076B2 · kind B2 · utility
73Cited by
128References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 31, 2011 |
| Grant date | Dec 31, 2013 |
| Priority date | — |
| Expiry date | Oct 22, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.